JP2010187666A5 - - Google Patents

Download PDF

Info

Publication number
JP2010187666A5
JP2010187666A5 JP2010016775A JP2010016775A JP2010187666A5 JP 2010187666 A5 JP2010187666 A5 JP 2010187666A5 JP 2010016775 A JP2010016775 A JP 2010016775A JP 2010016775 A JP2010016775 A JP 2010016775A JP 2010187666 A5 JP2010187666 A5 JP 2010187666A5
Authority
JP
Japan
Prior art keywords
fluorescence
baseline
ligand
ligand addition
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010016775A
Other languages
English (en)
Japanese (ja)
Other versions
JP5425651B2 (ja
JP2010187666A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010187666A publication Critical patent/JP2010187666A/ja
Publication of JP2010187666A5 publication Critical patent/JP2010187666A5/ja
Application granted granted Critical
Publication of JP5425651B2 publication Critical patent/JP5425651B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2010016775A 2002-12-18 2010-01-28 キメラアルファq−ガストデューシンgタンパク質 Expired - Lifetime JP5425651B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43479002P 2002-12-18 2002-12-18
US60/434,790 2002-12-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004559553A Division JP4654038B2 (ja) 2002-12-18 2003-12-17 キメラアルファq−ガストデューシンgタンパク質

Publications (3)

Publication Number Publication Date
JP2010187666A JP2010187666A (ja) 2010-09-02
JP2010187666A5 true JP2010187666A5 (https=) 2011-04-21
JP5425651B2 JP5425651B2 (ja) 2014-02-26

Family

ID=32595305

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004559553A Expired - Lifetime JP4654038B2 (ja) 2002-12-18 2003-12-17 キメラアルファq−ガストデューシンgタンパク質
JP2010016775A Expired - Lifetime JP5425651B2 (ja) 2002-12-18 2010-01-28 キメラアルファq−ガストデューシンgタンパク質

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004559553A Expired - Lifetime JP4654038B2 (ja) 2002-12-18 2003-12-17 キメラアルファq−ガストデューシンgタンパク質

Country Status (10)

Country Link
US (2) US7919236B2 (https=)
EP (1) EP1581555B1 (https=)
JP (2) JP4654038B2 (https=)
CN (1) CN1726224A (https=)
AT (1) ATE393778T1 (https=)
AU (1) AU2003286069A1 (https=)
CA (1) CA2507387A1 (https=)
DE (1) DE60320682T2 (https=)
ES (1) ES2305536T3 (https=)
WO (1) WO2004055048A2 (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7368285B2 (en) 2001-03-07 2008-05-06 Senomyx, Inc. Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same
DK2327985T3 (en) 2001-06-26 2016-09-05 Senomyx Inc H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds
AU2003286069A1 (en) * 2002-12-18 2004-07-09 Givaudan Sa Chimeric alpha q-gustducin g-proteins
WO2006046854A2 (en) 2004-10-29 2006-05-04 Quest International B.V. Flavour modulating substances
BRPI0518075B8 (pt) 2004-10-29 2017-05-16 Quest Int Services B V composição flavorizante, produto, e, processo de melhorar o flavor de um alimento, de uma bebida ou de um produto farmacêutico
DE602005015849D1 (de) 2005-09-02 2009-09-17 Givaudan Nederland Services B Geschmackverstärker
WO2007121604A2 (en) 2006-04-20 2007-11-01 Givaudan Sa Method relating to sweetness enhancement
US20110097741A1 (en) * 2006-04-20 2011-04-28 Jay Patrick Slack Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays
JP2009533065A (ja) * 2006-04-20 2009-09-17 ジボダン エス エー 味覚物質同定のための機能的方法
ATE444280T1 (de) 2006-05-05 2009-10-15 Givaudan Nederland Services B Zusammensetzung zur verbesserung von geschmack
US8039233B2 (en) * 2007-01-18 2011-10-18 Givaudan S.A. Nucleic acid sequences and their use in methods to identify umami modulatiors
EP1975611A1 (en) 2007-03-29 2008-10-01 Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand Agonists of bitter taste receptors and uses thereof
EP2137322B1 (en) * 2007-03-30 2013-02-27 Givaudan SA Methods to identify tas2r modulators
KR20100131969A (ko) * 2007-12-10 2010-12-16 메타프로테오믹스, 엘엘씨 암, 혈관신생 및 이와 관련된 염증 경로의 치환된 1,3-시클로펜타디온 다중-표적 단백질 키나아제 조절제
EP2108954A1 (en) 2008-04-10 2009-10-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. A test system for detecting intracellular cyclic nucleotide level and methods and uses thereof
US8546085B2 (en) * 2008-06-13 2013-10-01 Givaudan Sa Methods of identifying modulators of the bitter taste receptor TAS2R44
JP5576653B2 (ja) * 2008-12-26 2014-08-20 サントリー食品インターナショナル株式会社 環状ジペプチド含有飲料
EP2924112A1 (en) * 2009-02-02 2015-09-30 Chromocell Corporation Novel cell lines and methods
US20130123135A1 (en) 2010-05-07 2013-05-16 Jay Patrick Slack Methods To Identify Modulators of TAS2R48 Receptors
US20130115624A1 (en) 2010-05-07 2013-05-09 Givaudan S.A. Methods To Identify Modulators
JP5906013B2 (ja) * 2010-12-10 2016-04-20 花王株式会社 苦味抑制剤の評価・選択方法
EP2661266B1 (en) 2011-01-07 2020-09-16 Anji Pharma (US) LLC Chemosensory receptor ligand-based therapies
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
US9128079B2 (en) 2011-08-08 2015-09-08 The Coca-Cola Company Methods of using lung or bronchial epithelial cells to identify bitter taste modulators
WO2013072332A1 (en) 2011-11-14 2013-05-23 Givaudan Sa Methods of using antagonists of bitter taste receptors
KR20190120430A (ko) 2012-01-06 2019-10-23 엘셀릭스 테라퓨틱스 인코포레이티드 바이구아나이드 조성물 및 대사 장애를 치료하는 방법
EP2800562A2 (en) 2012-01-06 2014-11-12 Elcelyx Therapeutics, Inc. Compositions and methods for treating metabolic disorders
HK1210825A1 (en) 2012-07-11 2016-05-06 Elcelyx Therapeutics, Inc. Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
CN105101956B (zh) 2013-01-05 2018-12-07 埃尔舍利克斯治疗公司 包含双胍的延迟释放组合物
EP2983507B1 (en) 2013-03-15 2020-04-22 Applied Food Biotechnology, Inc. Feline bitter taste receptors and methods
US9804157B1 (en) 2013-03-15 2017-10-31 Senomyx, Inc. Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives
JP6367315B2 (ja) * 2013-05-10 2018-08-01 ペプシコ, インコーポレイテッドPepsiCo Inc. 潜在的味覚調節物質を特定するためのモデルとしての細胞
WO2014183041A1 (en) 2013-05-10 2014-11-13 Pepsico, Inc. Taste receptor internalization assay
JP6755640B2 (ja) 2014-03-28 2020-09-16 味の素株式会社 甘味受容体キメラタンパク質及びその利用
WO2017066799A1 (en) * 2015-10-16 2017-04-20 Cornell University Sweeteners having enhanced organoleptic properties
JP6924590B2 (ja) * 2016-03-14 2021-08-25 サントリーホールディングス株式会社 苦味評価のための融合タンパク質および苦味評価方法
CN108611324A (zh) * 2018-05-07 2018-10-02 云南中烟工业有限责任公司 一种稳定共表达重组人源甜味受体蛋白的真核细胞系及其制备方法
WO2025183058A1 (ja) * 2024-02-29 2025-09-04 味の素株式会社 植物由来タンパク質含有食品における異味・異風味をマスキングする物質のスクリーニング方法および異味・異風味のマスキング用の組成物
CN119193656A (zh) * 2024-09-24 2024-12-27 上海交通大学 一种响应鲜味信号的酵母细胞模型及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817759A (en) * 1992-04-09 1998-10-06 Linguagen Corporation Gustducin polypeptides and fragments
EP1214343A2 (en) 1999-09-10 2002-06-19 The Regents Of The University Of California T2r taste receptor family
US6462178B1 (en) * 1999-11-17 2002-10-08 Yong Hou Wong G protein
WO2002036622A2 (en) 2000-10-30 2002-05-10 Senomyx, Inc. GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS
US7041457B2 (en) * 2000-10-30 2006-05-09 Senomyx, Inc. Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors
AU2003286069A1 (en) * 2002-12-18 2004-07-09 Givaudan Sa Chimeric alpha q-gustducin g-proteins

Similar Documents

Publication Publication Date Title
JP2010187666A5 (https=)
Shiraki et al. α, β-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor γ
Si et al. Selective artificial transmembrane channels for protons by formation of water wires.
BR112014007332A2 (pt) mensagens de conclusão agregada em uma interface de banda lateral
DK2089343T3 (da) Click-kemi til fremstilling af reportermolekyler
PL398781A1 (pl) Sposoby i zestawy do prognozowania ryzyka wystapienia reakcji na wlew oraz zaniku odpowiedzi której posrednicza przeciwciala poprzez monitorowanie kwasu moczowego w surowicy podczas terapii z zastosowaniem pegylowanej urykazy
WO2017040930A3 (en) Biomarkers predictive of cytokine release syndrome
JP2015523003A5 (https=)
BRPI0907444A2 (pt) Estolides sulfonados e outros derivados de ácidos graxos, métodos de fazê-los, e composições e processos os empregam
CL2015000379A1 (es) Proteína de fusión que comprende un agonista de glp-1r, fgf-21 o un compuesto mimético y un conector; composición farmacéutica que la comprende; ácido nucleico que la codifica; vector; célula huésped; método de preparación; y uso para tratar enfermedad cardiovascular, diabetes mellitus y/o síndrome metabólico.
Milligan Orthologue selectivity and ligand bias: translating the pharmacology of GPR35
JP2012228272A5 (https=)
Seabrook et al. Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins
CN104853774A8 (zh) Il-20拮抗剂用于治疗肝脏疾病
EP2539354A4 (en) FOR RANTES-CODING NUCLEIC ACID MOLECULES AND COMPOSITIONS AND METHODS THEREWITH
Iwashima et al. Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension
HK1258716A1 (zh) 与表面结合的核酸分子的检测和量化
NO20090358L (no) Retinoid-induserbar faktor, og anvendelse derav
Bunnage et al. TAFIa inhibitors in the treatment of thrombosis.
JP2010528630A5 (https=)
WO2012068519A3 (en) Markers associated with response to activated protein c administration, and uses thereof
Chambers et al. Determinants of left ventricular mass in aortic stenosis.
Vaishampayan et al. An unusual case of isolated sixth cranial nerve palsy in leprosy.
Németh et al. Asymmetric dimethylarginine: predictor of cardiovascular diseases?
IuD et al. Thermodynamic models, describing formation of" bridges" between nucleic acid molecules and liquid crystals